Danaher Corporation Reports Second Quarter 2025 Results

Danaher Corporation, a leading global life sciences and diagnostics innovator, has released its financial results for the second quarter of 2025. The company reported a solid performance, driven by strong execution and growth in its Bioprocessing business.

Financial Highlights

For the quarter ended June 27, 2025, Danaher reported net earnings of $555 million, or $0.77 per diluted common share. On a non-GAAP basis, adjusted diluted net earnings per common share were $1.80. Revenues increased by 3.5% year-over-year to $5.9 billion, with non-GAAP core revenue growth of 1.5% year-over-year. Operating cash flow was $1.3 billion, and non-GAAP free cash flow was $1.1 billion.

Business and Operational Highlights

Danaher's Bioprocessing business showed robust growth, contributing significantly to the company's overall performance. The company also emphasized disciplined cost management, which helped exceed expectations for the quarter. The macro environment remains fluid, but Danaher believes its strong financial profile and differentiated portfolio will continue to generate sustainable, long-term value for shareholders.

Strategic Initiatives and Corporate Developments

While the report did not highlight any major corporate events or strategic initiatives, the company did increase its full-year adjusted diluted net earnings per common share guidance to a range of $7.70 to $7.80, up from the previous guidance of $7.60 to $7.75.

Management's Perspective

Rainer M. Blair, President and Chief Executive Officer, commented on the results, stating, "Our team’s strong execution using the Danaher Business System, paired with another quarter of robust growth in our Bioprocessing business and disciplined cost management, enabled us to exceed our expectations for the quarter." He added, "While the macro environment remains fluid, we believe the combination of our talented team, the differentiation of our portfolio, and our strong financial profile will enable us to continue generating sustainable, long-term value for shareholders for the remainder of 2025 and beyond."

Future Outlook

For the third quarter of 2025, Danaher anticipates non-GAAP core revenue growth in the low-single digits year-over-year. For the full year 2025, the company expects non-GAAP core revenue to grow approximately 3% year-over-year. The company has also increased its full-year adjusted diluted net earnings per common share guidance to a range of $7.70 to $7.80.

SEC Filing: DANAHER CORP /DE/ [ DHR ] - 8-K - Jul. 21, 2025